Gene · 10404
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sphingolipid Remodeling and Extracellular Vesicle Signatures Reflect Disease Severity in Facioscapulohumeral Dystrophy Driven by Mitochondrial Dysfunction and Endoplasmic Reticulum Stress. | Antioxidants (Basel) | 2026 | 42792205 | PubTator, text mining | PubMed |
| Evaluation of Antisense Oligonucleotide-Associated Neuronal Lysosomal Changes. | Nucleic Acid Ther | 2026 | 42560023 | PubTator, text mining | PubMed |
| Aminopeptidase Inhibition in Drug-Resistant Plasmodium falciparum: Structural, Functional, and Pharmacological Rationale for Targeting PfA-M1 and PfA-M17. | ChemMedChem | 2026 | 42493361 | PubTator, text mining | PubMed |
| Classification Under Local Differential Privacy with Model Reversal and Model Averaging. | J Mach Learn Res | 2026 | 42375467 | PubTator, text mining | PubMed |
| Sustainable Valorization of Gelatin Capsule Waste: Physicochemical and Antioxidant Properties of Derived Hydrolysates. | Antioxidants (Basel) | 2026 | 42352082 | PubTator, text mining | PubMed |
| Fluorogenic/chromogenic enzyme substrates constructed around the 2-amino-7-nitrofluorene core structure for the detection of aminopeptidase activities in clinically important microorganisms. | Bioorg Chem | 2026 | 42284875 | PubTator, text mining | PubMed |
| Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future Perspectives. | Cancers (Basel) | 2026 | 42192911 | PubTator, text mining | PubMed |
| Analysis of the <italic>Helicobacter pylori</italic> Proteases HP0087 and HP1037 Links HP0087 to Growth and Cell Length Defects. | Microb Physiol | 2026 | 42085348 | PubTator, text mining | PubMed |
| Extracellular Enzyme Activity Measurements Using Fluorescent Substrate Derivatives. | Methods Mol Biol | 2026 | 42062725 | PubTator, text mining | PubMed |
| In silico targeting of plasmodium falciparum metallo-aminopeptidases using hydroxamate inhibitors. | In Silico Pharmacol | 2026 | 41938380 | PubTator, text mining | PubMed |
| Bacillus subtilis Spore-Displayed Aminopeptidase from Pseudomonas aeruginosa Efficiently Degrades Pyrethroid Insecticides. | J Agric Food Chem | 2026 | 41921991 | PubTator, text mining | PubMed |
| Distinct metabolomic and proteomic signatures in Parkinson's disease patients with REM sleep behavior disorder. | Signal Transduct Target Ther | 2026 | 41912482 | PubTator, text mining | PubMed |
| Mendelian randomization implicates circulating plasma proteins in gout risk and identifies candidate therapeutic targets. | Int J Immunopathol Pharmacol | 2026 | 41885234 | PubTator, text mining | PubMed |
| Biomarker tests of progression from tuberculosis infection to disease: a systematic review. | Eur Respir Rev | 2026 | 41881453 | PubTator, text mining | PubMed |
| Hepatitis B virus, alcohol, and liver cancer. | Front Oncol | 2026 | 41788994 | PubTator, text mining | PubMed |
| Integrating computational engines to identify TSPAN6 as a migrasome-associated target for immunotherapy sensitization. | Front Immunol | 2026 | 41782878 | PubTator, text mining | PubMed |
| Internal bleaching: Comparing the effectiveness of Opalescence Endo and 30% hydrogen peroxide with sodium perborate - A randomized clinical trial. | J Conserv Dent Endod | 2026 | 41756802 | PubTator, text mining | PubMed |
| RNA cargo profiling of muscle extracellular vesicles identifies candidate biomarkers of disease activity and muscle degeneration in FSHD. | J Transl Med | 2026 | 41742280 | PubTator, text mining | PubMed |
| CRISPR screening redefines therapeutic target identification and drug discovery with precision and scalability. | J Pharm Anal | 2026 | 41732321 | PubTator, text mining | PubMed |
| NPEPPS segmental duplication drives position effect expression of TBC1D3 in the human brain. | bioRxiv | 2026 | 41648143 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10404/papers